Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes

被引:89
作者
Mun, Se Hwan [2 ]
Ko, Na Young [2 ]
Kim, Hyuk Soon [2 ]
Kim, Jie Wan [2 ]
Kim, Do Kyun [2 ]
Kim, A-Ram [2 ]
Lee, Seung Hyun [2 ,4 ]
Kim, Yong-Gil [3 ]
Lee, Chang Keun [3 ]
Lee, Seoung Hoon
Kim, Bo Kyung [2 ]
Beaven, Michael A. [5 ]
Kim, Young Mi [6 ]
Choi, Wahn Soo [1 ,2 ]
机构
[1] Konkuk Univ, Dept Immunol, Coll Med, Chungju 380701, South Korea
[2] Konkuk Univ, Inst Biomed Sci & Technol, Coll Med, Chungju 380701, South Korea
[3] Univ Ulsan, Div Rheumatol, Coll Med, Seoul 138736, South Korea
[4] Wonkwang Univ, Sch Dent, Dept Oral Microbiol & Immunol, Iksan 570749, South Korea
[5] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA
[6] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea
基金
美国国家卫生研究院;
关键词
Interleukin-33; Osteoclasts; Differentiation; Human CD14(+) monocytes; Bone resorption; KAPPA-B LIGAND; RHEUMATOID-ARTHRITIS; BONE-RESORPTION; THERAPEUTIC TARGET; RECEPTOR ACTIVATOR; IMMUNE-SYSTEM; MAST-CELLS; T-CELLS; IN-VIVO; IL-33;
D O I
10.1007/s00018-010-0410-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Interleukin (IL)-33 is a recently described pro-inflammatory cytokine. Here we demonstrate IL-33 as a regulator of functional osteoclasts (OCs) from human CD14(+) monocytes. IL-33 stimulates formation of tartrate-resistant acid phosphatase (TRAP)(+) multinuclear OCs from monocytes. This action was suppressed by anti-ST2 antibody, suggesting that IL-33 acts through its receptor ST2, but not by the receptor activator of NF-kappa B ligand (RANKL) decoy, osteoprotegerin, or anti-RANKL antibody. IL-33 stimulated activating phosphorylations of signaling molecules in monocytes that are critical for OC development. These included Syk, phospholipase C gamma 2, Gab2, MAP kinases, TAK-1, and NF-kappa B. IL-33 also enhanced expression of OC differentiation factors including TNF-alpha receptor-associated factor 6 (TRAF6), nuclear factor of activated T cells cytoplasmic 1, c-Fos, c-Src, cathepsin K, and calcitonin receptor. IL-33 eventually induced bone resorption. This study suggests that the osteoclastogenic property of IL-33 is mediated through TRAF6 as well as the immunoreceptor tyrosine-based activation motif-dependent Syk/PLC gamma pathway in human CD14(+) monocytes.
引用
收藏
页码:3883 / 3892
页数:10
相关论文
共 38 条
[1]
Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease [J].
Bendre, MS ;
Montague, DC ;
Peery, T ;
Akel, NS ;
Gaddy, D ;
Suva, LJ .
BONE, 2003, 33 (01) :28-37
[2]
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo [J].
Carriere, Virginie ;
Roussel, Lucie ;
Ortega, Nathalie ;
Lacorre, Delphine-Armelle ;
Americh, Laure ;
Aguilar, Luc ;
Bouche, Gerard ;
Girard, Jean-Philippe .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) :282-287
[3]
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex [J].
Chackerian, Alissa A. ;
Oldham, Elizabeth R. ;
Murphy, Erin E. ;
Schmitz, Jochen ;
Pflanz, Stefan ;
Kastelein, Robert A. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2551-2555
[4]
Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients:: semiquantitative and quantitative analysis [J].
Crotti, TN ;
Smith, MD ;
Weedon, H ;
Ahern, MJ ;
Findlay, DM ;
Kraan, M ;
Tak, PP ;
Haynes, DR .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (12) :1047-1054
[5]
LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis [J].
Edwards, J. R. ;
Sun, S. G. ;
Locklin, R. ;
Shipman, C. M. ;
Adamopoulos, I. E. ;
Athanasou, N. A. ;
Sabokbar, A. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1451-1462
[6]
Gadina M, 2007, SCI STKE, V390, ppe31
[7]
Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival [J].
Gingery, A ;
Bradley, E ;
Shaw, A ;
Oursler, MJ .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (01) :165-179
[8]
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases [J].
Hofbauer, LC ;
Schoppet, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (04) :490-495
[9]
IL-33 can promote survival, adhesion and cytokine production in human mast cells [J].
Iikura, Motoyasu ;
Suto, Hajime ;
Kajiwara, Naoki ;
Oboki, Keisuke ;
Ohno, Tatsukuni ;
Saito, Hirohisa ;
Galli, Stephen J. ;
Nakae, Susumu .
LABORATORY INVESTIGATION, 2007, 87 (10) :971-978
[10]
Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol [J].
Jiang, ZF ;
Jun, NT ;
Qian, YC ;
Matsumoto, K ;
Li, XX .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) :7158-7167